We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Galapagos Acquires Cangenix

News   Jan 16, 2013

 
Galapagos Acquires Cangenix
 
 
Advertisement
 

RELATED ARTICLES

Steroids May Offer COVID-19 Treatment Strategy in Patients With Endocrine Disorders

News

According to a new review, people with endocrine disorders may see their condition worsen as a result of COVID-19. The study authors note that mortality was shown to be lower in severely-ill patients with COVID-19 treated with the steroid dexamethasone.

READ MORE

Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2

News

Two peptides once combined, work together to penetrate cells' membranes in order to dampen an acute inflammatory response. In this first ex vivo study, the peptide reduced collagen degradation. The researchers say the peptide could alleviate some of the worst damage caused by acute inflammatory responses.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE